QNRX Buy Disclosure
Carter Denise P. · SEC Form 4 · Filed Sep 1, 2026
Buy
Calculated transaction value
$99.99K
Carter Denise P. Chief Operating Officer
QNRX
Transaction date
Aug 31, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 2 days later
QNRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- ADSs
- Quantity / price
- 20,490 shares @ $4.88
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-104405
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$99.99K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. QNRX Current | Buy | Aug 31, 2026 | $99.99K |
| Quoin Pharmaceuticals, Ltd. QNRX | Buy | Aug 31, 2026 | Not reported |